Triple primer polymerase chain reaction: A new way to quantify truncated mRNA expression

American Journal of Pathology

Volumn 148, Issue 4, 1996, Pages 1097-1103

  Leygue, Etienne ^a   Murphy, Leigh ^a   Kuttenn, Frederique ^b   Watson, Peter ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; MESSENGER RNA;

ARTICLE; BREAST TUMOR; CARCINOGENESIS; EXON; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BASE SEQUENCE; BREAST; BREAST DISEASES; CLONING, MOLECULAR; DNA PRIMERS; DNA, COMPLEMENTARY; FEMALE; HUMANS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; RECEPTORS, ESTROGEN; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0029921874     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Jin Y, Dietz HC, Nurden A, Bray P: Single-strand conformation polymorphism analysis is a rapid and effective method for the identification of mutations and polymorphisms in the gene for glycoprotein IIIa. Blood 1993, 8.2281-2288
2. Ikonen E, Aula P, Gron K, Tollersrud O, Halila R, Manninen T, Syvanen AC, Peltonen L: Spectrum of mutations in aspartylglucosaminaria. Proc Natl Acad Sci USA 1991, 88:11222-11226
3. Chelly J, Gilgenkrantz H, Lambert M, Hamard Q, Chafey P, Recan D, Katz P, de la Chapelle A, Koenig M, Ginjaar IB, Fardeau M, Tome F, Kahn A, Kaplan JC: Effect of dystrophin gene deletions on mRNA levels and processing in Duchenne and Becker dystrophies. Cell 1990, 63:1239-1248
4. Patriots C, Makris A, Bear SE, Tsichlis PN: Tumor progression locus 2 (Tpl-2) encodes a protein kinase involved in the progression of rodent T-cell lymphomas and in T-cell activation. Proc Natl Acad Sci USA 1993, 90:2251-2255
5. Yamamoto K, Seto M, Akao Y, Lida S, Nakasawa S, Oshimura M, Takahashi T, Ueda R. Gene rearrangement and truncated mRNA in cell lines with 11q23 translocation Oncogene 1993, 8.479-485
6. Garcia T, Lehrer S, Bloomer WD, Schachter B. A variant estrogen receptor messenger ribonucleic acid is associated with reduced levels of estrogen binding in human mammary tumors Mol Endocrinol 1988, 2:785-791
7. Murphy LC, Dotzlaw H: Variant estrogen receptor mRNA species detected in human breast cancer biopsy samples. Mol Endocrinol 1989, 3.687-693
8. Fuqua SAW, Fitzgerald SD, Chamness GC, Tandon AK, McDonnell DP, Nawaz Z, O'Malley B, McGuire WL Variant human breast tumor estrogen receptor with constitutive transcriptional activity. Cancer Res 1991, 51.105-109
9. McGuire WL, Chamness GC, Fuqua SAW: Abnormal estrogen receptor in clinical breast cancer J Steroid Biochem Mol Biol 1992, 43 243-247
10. Becker-Andre M, Hahlbrock K: Absolute mRNA quantification using polymerase chain reaction (PCR). A novel approach by a PCR aided transcript titration assay (PATTY). Nucleic Acids Res 1989, 17:9437-9446
11. Scadden DT, Wang Z, Groopman JE: Quantitation of plasma human immunodeficiency virus type 1 RNA by competitive polymerase chain reaction. J Infect Dis 1992, 165 1119-1123
12. Siebertt PD, Larrick JW: Competitive PCR Nature 1992, 359.557-558
13. Spanakis E. Determining the specificity of quantitative variation in gene expression. J Natl Cancer Inst 1995, 87.1179-1180
14. Riedy MC, Timm EA, Stewart CC: Quantitative RT-PCR for measuring gene expression. Biotechniques 1995, 18:70-76
15. Levesques Q, Lamarche B, Murthy MRV, Julien P, Despres JP, Deshaies Y. Determination of changes in specific gene expression by reverse transcription PCR using interspecies mRNAs as internal standards. Biotechniques 1994, 17:738-741
16. Dotzlaw H, Alkhalaf M, Murphy LC: Characterization of estrogen receptor variant mRNAs from human breast cancers Mol Endocrinol 1992, 6.773-785
17. Murphy LC, Hisenbeck SG, Dotzlaw H, Fuqua SAW: Relationship of clone 4 estrogen receptor variant messenger RNA expression to some known prognostic variables in human breast cancer Clin Cancer Res 1995, 1.155-159
18. Murphy LC, Dotzlaw H: Regulation of transforming growth factor a and transforming growth factor β messenger ribonucleic acid abundance in T-47D human breast cancer cells Mol Endocrinol 1989, 3:611-617
19. Tora L, Mullick A, Metzger D, Ponglikitmongkol M, Park I, Chambon P. The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties. Embo J 1989, 8:1981-1986
20. Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P, Chambon P: Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 1986, 320:134-139
21. Krett NL, Pillay S, Moalli PA, Greipp PR, Rosen ST: A variant glucocorticoid receptor messenger RNA is expressed in multiple myeloma patients. Cancer Res 1995, 55:2727-2729
22. Wang Y, Miksicek RJ. Identification of a dominant negalive form of the human estrogen receptor. Mol Endocrinol 1991, 5 1707-1715
23. Fuqua SAW, Fitzgerald SD, Allred DC, Elledge RM, Nawaz Z, McDonnell DP, O'Malley BW, Greene GL, McGuire WL: Inhibition of estrogen receptor activity by a naturally occurring variant in human breast tumors. Cancer Res 1992, 52.483-486
24. Fuqua SAW, Allred DC, Elledge RM, Krieg SL, Benedix MG, Nawaz Z, O'Malley BW, Greene GL, McGuire WL. The ER-positive/PgR negative breast cancer phenotype is not associated with mutations within the DNA binding domain Breast Cancer Res Treat 1993, 26 191-202
25. Leygue E, Watson PW, Murphy LC: Estrogen receptor variants in normal human mammary tissue J Natl Cancer Inst (In press)
26. Pfeffer U, Fecarotta E, Vidali G: Coexpression of multiple estrogen receptor variant messenger RNAs in normal and neoplastic breast tissues and in MCF-7 cells. Cancer Res 1995, 55:2158-2165
27. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB: Bcl-x, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993, 74:597-608
28. Oltvai ZN, Milliman CL, Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death Cell 1993, 74:609-619
29. Ellinger-Ziegelbauer H, Glaser B, Dreyer C: A naturally occunng short variant of the FTZ-F1-related nuclear orphan receptor xFF1rA and interactions between domains of xFF1rA. Mol Endocrinol 1995, 9 872-886